T1	CHEM 16 27	ropivacaína
#1	AnnotatorNotes T1	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T2	PROC 55 87	control del dolor postoperatorio
T3	DISO 67 87	dolor postoperatorio
#2	AnnotatorNotes T3	C0030201; Pain, Postoperative; Sign or Symptom
T4	PROC 91 125	cirugía ginecológica laparoscópica
T5	PROC 906 948	Se evaluó el dolor abdominal y/o de hombro
T6	PROC 141 163	Determinar la eficacia
#3	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
T7	CHEM 202 213	ropivacaína
#4	AnnotatorNotes T7	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T8	PROC 245 286	control del dolor abdominal y/o de hombro
T9	DISO 257 286	dolor abdominal y/o de hombro
T10	ANAT 280 286	hombro
#5	AnnotatorNotes T10	C0037004; Shoulder; Body Location or Region | C1283792; Entire shoulder region; Body Location or Region
T11	PROC 320 354	cirugía laparoscópica ginecológica
T12	PROC 547 581	cirugía laparoscópica ginecológica
T13	PROC 629 643	neumoperitoneo
#6	AnnotatorNotes T13	C0198632; Surgical pneumoperitoneum; Therapeutic or Preventive Procedure
T14	CHEM 672 683	ropivacaína
#7	AnnotatorNotes T14	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T15	CHEM 692 709	suero fisiológico
#8	AnnotatorNotes T15	C0445115; Normal saline; Inorganic Chemical · Pharmacologic Substance
T16	CHEM 805 809	AINE
#9	AnnotatorNotes T16	C0003211; Anti-Inflammatory Agents, Non-Steroidal; Pharmacologic Substance
T17	PROC 833 836	PCA
#10	AnnotatorNotes T17	C0078944; Patient-Controlled Analgesia; Therapeutic or Preventive Procedure
T18	CHEM 851 858	morfina
#11	AnnotatorNotes T18	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T19	DISO 919 948	dolor abdominal y/o de hombro
T20	PROC 1388 1391	ENV
T21	PROC 862 869	rescate
#12	AnnotatorNotes T21	C0085405; Salvage Therapy; Therapeutic or Preventive Procedure
T22	ANAT 942 948	hombro
#13	AnnotatorNotes T22	C0037004; Shoulder; Body Location or Region | C1283792; Entire shoulder region; Body Location or Region
T23	CHEM 1072 1079	morfina
#14	AnnotatorNotes T23	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T24	DISO 1124 1159	náuseas y/o vómitos postoperatorios
#15	AnnotatorNotes T24	C0520909; Postoperative Nausea and Vomiting; Sign or Symptom
T25	PROC 1183 1202	encuesta telefónica
#16	AnnotatorNotes T25	C0681820; telephone survey; Research Activity
T26	DISO 1232 1247	dolor de hombro
#17	AnnotatorNotes T26	C0037011; Shoulder Pain; Sign or Symptom
T27	DISO 1286 1301	dolor abdominal
#18	AnnotatorNotes T27	C0000737; Abdominal Pain; Sign or Symptom
T28	CHEM 1474 1481	morfina
#19	AnnotatorNotes T28	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T29	DISO 1503 1522	náuseas y/o vómitos
#20	AnnotatorNotes T29	C0027498; Nausea and vomiting; Sign or Symptom
T30	DISO 1531 1546	dolor de hombro
#21	AnnotatorNotes T30	C0037011; Shoulder Pain; Sign or Symptom
T31	DISO 1628 1643	dolor abdominal
#22	AnnotatorNotes T31	C0000737; Abdominal Pain; Sign or Symptom
T32	PROC 1684 1695	tratamiento
#23	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	CHEM 1816 1827	ropivacaína
#24	AnnotatorNotes T33	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T34	CHEM 1874 1891	suero fisiológico
#25	AnnotatorNotes T34	C0445115; Normal saline; Inorganic Chemical · Pharmacologic Substance
T35	PROC 1915 1957	técnica anestésica y analgésica multimodal
T36	DISO 1987 2007	dolor postoperatorio
#26	AnnotatorNotes T36	C0030201; Pain, Postoperative; Sign or Symptom
T37	CHEM 2023 2031	opioides
#27	AnnotatorNotes T37	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T38	DISO 2052 2085	náuseas y vómitos postoperatorios
#28	AnnotatorNotes T38	C0520909; Postoperative Nausea and Vomiting; Sign or Symptom
T39	DISO 2148 2163	dolor de hombro
#29	AnnotatorNotes T39	C0037011; Shoulder Pain; Sign or Symptom
T40	PROC 2193 2227	cirugía laparoscópica ginecológica
T41	CHEM 2239 2250	ropivacaína
#30	AnnotatorNotes T41	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T42	DISO 2366 2381	dolor abdominal
#31	AnnotatorNotes T42	C0000737; Abdominal Pain; Sign or Symptom
T43	PROC 170 198	administración preincisional
T44	ANAT 263 272	abdominal
#32	AnnotatorNotes T44	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T45	PROC 373 414	Ensayo clínico aleatorizado y doble ciego
#33	AnnotatorNotes T45	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T46	PROC 451 492	ensayo clínico aleatorizado y doble ciego
#34	AnnotatorNotes T46	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T47	DISO 586 603	patología benigna
T48	PROC 875 895	analgesia multimodal
#35	AnnotatorNotes T48	C5396580; Administration of multimodal anesthesia; Therapeutic or Preventive Procedure
T49	ANAT 925 934	abdominal
#36	AnnotatorNotes T49	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T50	ANAT 1241 1247	hombro
#37	AnnotatorNotes T50	C0037004; Shoulder; Body Location or Region | C1283792; Entire shoulder region; Body Location or Region
T51	ANAT 1292 1301	abdominal
#38	AnnotatorNotes T51	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T52	ANAT 1540 1546	hombro
#39	AnnotatorNotes T52	C0037004; Shoulder; Body Location or Region | C1283792; Entire shoulder region; Body Location or Region
T53	ANAT 1634 1643	abdominal
#40	AnnotatorNotes T53	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T54	PROC 1758 1802	administración intraperitoneal preincisional
T55	PROC 1856 1891	administración de suero fisiológico
#41	AnnotatorNotes T55	C0199797; Infusion of saline solution; Therapeutic or Preventive Procedure
T56	ANAT 2157 2163	hombro
#42	AnnotatorNotes T56	C0037004; Shoulder; Body Location or Region | C1283792; Entire shoulder region; Body Location or Region
T57	ANAT 2372 2381	abdominal
#43	AnnotatorNotes T57	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T58	Route 33 48	intraperitoneal
#44	AnnotatorNotes T58	C1522583; Intraperitoneal Route of Drug Administration; Functional Concept
T59	Date 73 87	postoperatorio
#45	AnnotatorNotes T59	C0032790; Postoperative Period; Temporal Concept
T60	Dose 214 222	al 0,1 %
T61	Route 223 238	intraperitoneal
#46	AnnotatorNotes T61	C1522583; Intraperitoneal Route of Drug Administration; Functional Concept
T62	Duration 296 313	la primera semana
T63	LIVB 515 524	pacientes
#47	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Dose 662 668	100 ml
T65	Route 710 725	intraperitoneal
#48	AnnotatorNotes T65	C1522583; Intraperitoneal Route of Drug Administration; Functional Concept
T66	LIVB 775 784	pacientes
#49	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	DEVI 824 836	bomba de PCA
#50	AnnotatorNotes T67	C0181331; PCA Pump; Medical Device
T68	PHYS 952 961	despertar
#51	AnnotatorNotes T68	C0442696; Waking; Physiologic Function
T69	Duration 992 1019	los 5, 30, 60 y 120 minutos
T70	Duration 1032 1044	las 24 horas
T71	Duration 1083 1104	las primeras 24 horas
T72	Date 1144 1159	postoperatorios
#52	AnnotatorNotes T72	C0032790; Postoperative Period; Temporal Concept
T73	Duration 1163 1172	la semana
T74	Duration 1260 1272	las 24 horas
T75	Date 1317 1323	7o día
T77	Duration 1400 1421	las primeras 24 horas
T79	Date 1659 1665	7o día
T80	LIVB 1711 1724	grupo control
#53	AnnotatorNotes T80	C0009932; Control Groups; Group
T81	Route 1773 1788	intraperitoneal
#54	AnnotatorNotes T81	C1522583; Intraperitoneal Route of Drug Administration; Functional Concept
T82	Dose 1806 1812	100 ml
T84	Date 1993 2007	postoperatorio
#55	AnnotatorNotes T84	C0032790; Postoperative Period; Temporal Concept
T86	Date 2070 2085	postoperatorios
#56	AnnotatorNotes T86	C0032790; Postoperative Period; Temporal Concept
T87	Duration 2089 2110	las primeras 24 horas
T89	Date 2177 2187	primer día
T90	Dose 2251 2259	al 0,1 %
T91	Route 2260 2275	intraperitoneal
#57	AnnotatorNotes T91	C1522583; Intraperitoneal Route of Drug Administration; Functional Concept
T94	PHYS 978 988	movimiento
#58	AnnotatorNotes T94	C0026649; Movement; Organism Function
T96	Dose 28 32	0,1%
T97	Dose 684 689	0,1 %
T98	Time 2276 2289	preincisional
T83	Time 185 198	preincisional
T92	Time 1789 1802	preincisional
T76	LIVB 1678 1695	grupo tratamiento
#59	AnnotatorNotes T76	C5205742; Treatment Group; Population Group
T78	PROC 525 528	ASA
#60	AnnotatorNotes T78	C4751522; Assessment using American Society of Anesthesiologists Physical Status Classification System; Health Care Activity
T85	Date 2397 2426	séptimo día de postoperatorio
T88	Neg_cue 1959 1961	no
T93	Observation 1976 2007	reducir el dolor postoperatorio
A1	Assertion T93 Negated
R1	Negation Arg1:T88 Arg2:T93	
T95	Neg_cue 1338 1340	No
T99	CONC 1355 1366	diferencias
A2	Assertion T99 Negated
#61	AnnotatorNotes T99	C1705241; Delta (difference); Quantitative Concept
R2	Negation Arg1:T95 Arg2:T99	
T100	Neg_cue 2112 2119	Tampoco
T101	Observation 2134 2163	reducción del dolor de hombro
A3	Assertion T101 Negated
R3	Negation Arg1:T100 Arg2:T101	
T102	Neg_cue 1423 1430	Tampoco
R4	After Arg1:T101 Arg2:T89	
R5	After Arg1:T101 Arg2:T40	
T103	CONC 1445 1456	diferencias
A4	Assertion T103 Negated
#62	AnnotatorNotes T103	C1705241; Delta (difference); Quantitative Concept
R6	Negation Arg1:T102 Arg2:T103	
T104	CONC 963 972	en reposo
#63	AnnotatorNotes T104	C0443144; At rest; Functional Concept
R7	Overlap Arg1:T5 Arg2:T104	
R8	Overlap Arg1:T5 Arg2:T68	
R9	Overlap Arg1:T5 Arg2:T94	
R10	Location_of Arg1:T49 Arg2:T19	
R11	Location_of Arg1:T22 Arg2:T19	
R13	Overlap Arg1:T5 Arg2:T69	
R14	Overlap Arg1:T5 Arg2:T70	
R15	Has_Dose_or_Strength Arg1:T1 Arg2:T96	
R16	Has_Route_or_Mode Arg1:T1 Arg2:T58	
R18	Overlap Arg1:T3 Arg2:T59	
R19	Overlap Arg1:T2 Arg2:T59	
R20	Causes Arg1:T4 Arg2:T3	
R21	Used_for Arg1:T1 Arg2:T2	
R22	Used_for Arg1:T7 Arg2:T43	
R23	Overlap Arg1:T7 Arg2:T83	
R24	Has_Dose_or_Strength Arg1:T7 Arg2:T60	
R25	Has_Route_or_Mode Arg1:T7 Arg2:T61	
R26	Before Arg1:T43 Arg2:T11	
R27	Location_of Arg1:T44 Arg2:T9	
R28	Location_of Arg1:T10 Arg2:T9	
R30	Has_Duration_or_Interval Arg1:T8 Arg2:T62	
R31	Causes Arg1:T11 Arg2:T9	
R32	Before Arg1:T11 Arg2:T8	
T105	Quantifier_or_Qualifier 355 362	benigna
#64	AnnotatorNotes T105	C0205183; Benign; Qualitative Concept
R33	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T105	
R34	Experiences Arg1:T63 Arg2:T78	
T106	Result_or_Value 529 534	I-III
R35	Has_Result_or_Value Arg1:T78 Arg2:T106	
R36	Before Arg1:T78 Arg2:T12	
R37	Experiences Arg1:T63 Arg2:T12	
R38	Experiences Arg1:T63 Arg2:T47	
R39	Before Arg1:T13 Arg2:T14	
R40	Before Arg1:T13 Arg2:T15	
R41	Has_Dose_or_Strength Arg1:T14 Arg2:T64	
R42	Has_Dose_or_Strength Arg1:T14 Arg2:T97	
R43	Has_Route_or_Mode Arg1:T15 Arg2:T65	
R44	Experiences Arg1:T66 Arg2:T16	
R45	Combined_with Arg1:T16 Arg2:T67	
R46	Used_for Arg1:T67 Arg2:T17	
R47	Used_for Arg1:T18 Arg2:T17	
R48	Used_for Arg1:T18 Arg2:T21	
R49	Used_for Arg1:T18 Arg2:T48	
R50	Experiences Arg1:T66 Arg2:T17	
R51	Experiences Arg1:T66 Arg2:T18	
R52	Experiences Arg1:T66 Arg2:T48	
R53	Has_Duration_or_Interval Arg1:T23 Arg2:T71	
R54	Overlap Arg1:T24 Arg2:T72	
R55	Overlap Arg1:T25 Arg2:T73	
R56	Location_of Arg1:T50 Arg2:T26	
R58	After Arg1:T26 Arg2:T74	
R59	Location_of Arg1:T51 Arg2:T27	
R60	Overlap Arg1:T27 Arg2:T75	
T107	Quantifier_or_Qualifier 1302 1313	persistente
#65	AnnotatorNotes T107	C0205322; Persistent; Temporal Concept
R61	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T107	
R57	Location_of Arg1:T53 Arg2:T31	
T108	Quantifier_or_Qualifier 1644 1655	persistente
#66	AnnotatorNotes T108	C0205322; Persistent; Temporal Concept
R62	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T108	
R65	Overlap Arg1:T99 Arg2:T77	
T109	Quantifier_or_Qualifier 1367 1381	significativas
A5	Assertion T109 Negated
#67	AnnotatorNotes T109	C0237881; Statistical Significance; Quantitative Concept
R66	Has_Quantifier_or_Qualifier Arg1:T99 Arg2:T109	
R67	Negation Arg1:T95 Arg2:T109	
R68	Location_of Arg1:T52 Arg2:T30	
R69	Overlap Arg1:T31 Arg2:T79	
R70	Experiences Arg1:T76 Arg2:T32	
R71	Experiences Arg1:T76 Arg2:T31	
R72	Experiences Arg1:T80 Arg2:T31	
R73	Has_Dose_or_Strength Arg1:T33 Arg2:T82	
R74	Overlap Arg1:T33 Arg2:T92	
R75	Has_Route_or_Mode Arg1:T33 Arg2:T81	
R76	Used_for Arg1:T33 Arg2:T54	
T110	Dose 1828 1833	0,1 %
R77	Has_Dose_or_Strength Arg1:T33 Arg2:T110	
R78	Used_for Arg1:T34 Arg2:T55	
R79	Before Arg1:T55 Arg2:T35	
R80	Before Arg1:T54 Arg2:T35	
R81	Before Arg1:T54 Arg2:T93	
R82	Before Arg1:T55 Arg2:T93	
R83	Overlap Arg1:T36 Arg2:T84	
R84	Overlap Arg1:T93 Arg2:T36	
R85	Overlap Arg1:T38 Arg2:T86	
R86	Has_Duration_or_Interval Arg1:T38 Arg2:T87	
R87	Has_Duration_or_Interval Arg1:T36 Arg2:T87	
R88	Has_Duration_or_Interval Arg1:T37 Arg2:T87	
R89	Causes Arg1:T35 Arg2:T38	
R90	Location_of Arg1:T56 Arg2:T39	
R91	Location_of Arg1:T56 Arg2:T101	
T111	Observation 1976 1983;2012 2031	reducir consumo de opioides
A6	Assertion T111 Negated
R93	Negation Arg1:T88 Arg2:T111	
R94	Negation Arg1:T88 Arg2:T111	
T112	Observation 1976 1983;2052 2085	reducir náuseas y vómitos postoperatorios
A7	Assertion T112 Negated
R95	Negation Arg1:T88 Arg2:T112	
R96	Has_Dose_or_Strength Arg1:T41 Arg2:T90	
R97	Has_Route_or_Mode Arg1:T41 Arg2:T91	
R98	Overlap Arg1:T41 Arg2:T98	
T113	Observation 2303 2314;2363 2381	disminución de dolor abdominal
R99	Location_of Arg1:T57 Arg2:T42	
R100	Location_of Arg1:T57 Arg2:T113	
R101	Overlap Arg1:T113 Arg2:T42	
T114	Quantifier_or_Qualifier 2382 2393	persistente
#68	AnnotatorNotes T114	C0205322; Persistent; Temporal Concept
R102	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T114	
R103	Causes Arg1:T41 Arg2:T113	
R104	Overlap Arg1:T113 Arg2:T85	
R105	Overlap Arg1:T42 Arg2:T85	
#69	AnnotatorNotes T20	C4275132; Assessment using Verbal Rating Scale; Diagnostic Procedure
R12	Overlap Arg1:T20 Arg2:T77	
R17	Overlap Arg1:T93 Arg2:T84	
R29	Overlap Arg1:T112 Arg2:T86	
A8	Experiencer T63 Patient
A9	Experiencer T66 Patient
A10	Experiencer T76 Patient
A11	Experiencer T80 Patient
